The Pharmaceutical Journal
Vol 271 No 7270 p484
11 October 2003

This article
Reprint
Photocopy

News summary

Related websites
Consultation on the reclassification of Galpharm hayfever and allergy relief syrup and hayfever and allergy relief tablets (Microsoft Word document)

GSL application for cetirizine syrup

Galpharm has applied for its hayfever and allergy relief syrup (citirizine hydrochloride 1mg/1ml) and tablets (cetirizine hydrochloride 10mg) to be reclassified as general sale list medicines. Comments on Medicines and Healthcare products Regulatory Agency consultation (Microsoft Word) document ARM 12 can be made until 23 October.